Jpmorgan Chase & CO Inogen Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Inogen Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 872,215 shares of INGN stock, worth $7.88 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
872,215
Previous 904,326
3.55%
Holding current value
$7.88 Million
Previous $7.3 Million
2.82%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding INGN
# of Institutions
136Shares Held
22MCall Options Held
122KPut Options Held
35.4K-
Divisadero Street Capital Management, LP Miami, FL2.35MShares$21.2 Million3.29% of portfolio
-
Camber Capital Management LP Boston, MA2MShares$18.1 Million0.45% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.95MShares$17.6 Million0.33% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$14.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$13 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $206M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...